Orient EuroPharma Co., Ltd. (TPEX:4120)

Taiwan · Delayed Price · Currency is TWD

44.60

+0.25 (0.56%)

May 29, 2026, 1:30 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Nutrition and Health Sector	1.69B	1.65B	2.17B	2.40B	2.54B
Nutrition and Health Sector Growth	2.38%	-23.96%	-9.86%	-5.29%	-23.70%
Western Medicine Segment	2.91B	2.74B	2.43B	2.33B	2.23B
Western Medicine Segment Growth	6.00%	13.12%	4.23%	4.38%	8.33%
Total	4.60B	4.39B	4.59B	4.73B	4.77B
Total Growth	4.64%	-4.37%	-2.93%	-0.77%	-11.45%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan	3.22B	3.08B	2.88B	2.79B	2.70B
Taiwan Growth	4.58%	6.85%	3.57%	3.30%	3.13%
China	158.77M	242.25M	701.54M	1.04B	1.23B
China Growth	-34.46%	-65.47%	-32.24%	-15.51%	-36.16%
Southeast Asia	1.21B	1.06B	992.73M	909.69M	845.25M
Southeast Asia Growth	13.71%	7.24%	9.13%	7.62%	-0.52%
Other	2.03M	1.98M	12.74M	-	-
Other Growth	2.83%	-84.48%	-	-	-
Total	4.60B	4.39B	4.59B	4.73B	4.77B
Total Growth	4.64%	-4.37%	-2.93%	-0.77%	-11.45%

Source: S&P Global Market Intelligence.